Q&A with Former Patient Morgan Paine and his consultant Lindsay George, as they talk about his diagnosis to treatment.
Morgan was diagnosed in 2019 with Acute Lymphoblastic Leukaemia (ALL) and is currently undergoing treatment for ALL at our Trials Acceleration Centre at the CCH, based at Queen Elizabeth Hospital Birmingham.
Morgan and Lindsay have an honest discussion about Morgan’s diagnosis and treatment, and the long-term effect the treatment has had on him personally and his pathways.
On World AML Awareness Day, through continued investment in the Trials Acceleration Programme (TAP) network, Cure Leukaemia are proud to announce two major clinical trials are on the horizon, EVOLVE 1 and 2.
"I called it the ‘little c’ to take away its power. Through chemo, a stem cell transplant, and life-threatening setbacks, Cathy's AML is now cured.
Notifications
